Dose optimisation and dose intensification in malignant lymphoma

This publication has 13 references indexed in Scilit:

• A randomised dose intensity study in ovarian carcinoma comparing chemotherapy given at four week intervals for six cycles with half dose chemotherapy given for twelve cycles
  Annals of Oncology, 1993
• Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma
  New England Journal of Medicine, 1993
• Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial
  The Lancet, 1993
• The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight- year study of 155 patients
  Blood, 1993
• Chemotherapy of Advanced Hodgkin's Disease with MOPP, ABVD, or MOPP Alternating with ABVD
  New England Journal of Medicine, 1992
• Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial
  Blood, 1992
• Peripheral Blood Stem Cell Transplantation: Historical Perspective, Current Status, and Prospects for the Future
  Transfusion Medicine Reviews, 1992
• The potential value of very intensive therapy with autologous bone marrow rescue in the treatment of malignant lymphomas
  Hematological Oncology, 1987
• A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy.
  Journal of Clinical Oncology, 1983
• Alternating Drug Combinations in the Treatment of Advanced Hodgkin's Disease
  New England Journal of Medicine, 1982